Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trialJean Bennett, Albert M. Maguire, Jennifer Wellman et al.|The Lancet|2016Cited by 464
Amelioration of Neurosensory Structure and Function in Animal and Cellular Models of a Congenital BlindnessJi Yun Song, Jean Bennett, Daniel J. Bennett et al.|Molecular Therapy|2018Cited by 27
Restoration of Vision and Retinal Responses After Adeno-Associated Virus–Mediated Optogenetic Therapy in Blind DogsSergei Nikonov, Jean Bennett, Puya Aravand et al.|Translational Vision Science & Technology|2022Cited by 19
rAAV-mediated gene augmentation improves retinal and visual function and retinal structure in a mouse model for LCA5Ji Yun Song, Jean Bennett, Puya Aravand et al.|Investigative Ophthalmology & Visual Science|2016Cited by 0
Intravitreal injection of AAV7m8.hLCA5 restores photoreceptor function in Lca5-/- mice to nearly WT levels.Puya Aravand, Sergei Nikonov, Ji Yun Song et al.|Investigative Ophthalmology & Visual Science|2017Cited by 0